* . *
  • About
  • Advertise
  • Privacy & Policy
  • Contact
Saturday, September 6, 2025
Earth-News
  • Home
  • Business
  • Entertainment
    Pendulum Announce Homecoming 2026 Australian Tour – yahoo.com

    Pendulum Announces Thrilling Homecoming Tour Across Australia in 2026

    ITV Studios Launches New Entertainment Label – Global Bulletin – IMDb

    ITV Studios Unveils Exciting New Entertainment Label

    TS Entertainment bringing Malibu Jack’s to former Owensboro mall – Lane Report

    TS Entertainment Launches Malibu Jack’s at Former Owensboro Mall Location

    Jenny Han Dropped a Major ‘The Summer I Turned Pretty’ Easter Egg Revealing [SPOILER] – yahoo.com

    Jenny Han Just Unveiled a Huge ‘The Summer I Turned Pretty’ Easter Egg That Changes Everything [SPOILER]

    Liam Payne’s Cousin Ross Harris Honors Late Singer With Emotional Song ‘Bones’ – yahoo.com

    Liam Payne’s Cousin Ross Harris Honors Late Singer with Emotional New Song ‘Bones

    Country music star apologizes after drunken show ends with cops taking him down: ‘I’m not OK’ – PennLive.com

    Country Music Star Apologizes After Drunken Show Ends in Police Intervention: ‘I’m Not OK

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology
    Coherent Joins LLNL’s STARFIRE Diode Technology Working Group to Advance Inertial Fusion Energy – GlobeNewswire

    Coherent Partners with LLNL’s STARFIRE Team to Drive Breakthroughs in Inertial Fusion Energy

    Gene Associated With Deadly Heart Disease in Golden Retrievers Identified – Technology Networks

    Breakthrough Discovery Uncovers Gene Behind Deadly Heart Disease in Golden Retrievers

    Monkey Island LNG Picks ConocoPhillips’ Liquefaction Technology – Hart Energy

    Monkey Island LNG Selects ConocoPhillips’ Advanced Liquefaction Technology for Next-Gen Energy Solutions

    Credo Technology Group Holding Ltd. (CRDO) Surpasses Q1 Earnings and Revenue Estimates – Yahoo Finance

    Credo Technology Group Surpasses Q1 Earnings and Revenue Expectations

    The Economist is hiring a science and technology correspondent – The Economist

    Exciting Opportunity: Become Our Next Science and Technology Correspondent!

    Blockchain lender Figure Technology seeks to raise up to $526M in IPO (FIGR:Pending) – Seeking Alpha

    Blockchain Lender Figure Technology Sets Sights on $526M in Thrilling IPO Launch

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
  • Home
  • Business
  • Entertainment
    Pendulum Announce Homecoming 2026 Australian Tour – yahoo.com

    Pendulum Announces Thrilling Homecoming Tour Across Australia in 2026

    ITV Studios Launches New Entertainment Label – Global Bulletin – IMDb

    ITV Studios Unveils Exciting New Entertainment Label

    TS Entertainment bringing Malibu Jack’s to former Owensboro mall – Lane Report

    TS Entertainment Launches Malibu Jack’s at Former Owensboro Mall Location

    Jenny Han Dropped a Major ‘The Summer I Turned Pretty’ Easter Egg Revealing [SPOILER] – yahoo.com

    Jenny Han Just Unveiled a Huge ‘The Summer I Turned Pretty’ Easter Egg That Changes Everything [SPOILER]

    Liam Payne’s Cousin Ross Harris Honors Late Singer With Emotional Song ‘Bones’ – yahoo.com

    Liam Payne’s Cousin Ross Harris Honors Late Singer with Emotional New Song ‘Bones

    Country music star apologizes after drunken show ends with cops taking him down: ‘I’m not OK’ – PennLive.com

    Country Music Star Apologizes After Drunken Show Ends in Police Intervention: ‘I’m Not OK

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology
    Coherent Joins LLNL’s STARFIRE Diode Technology Working Group to Advance Inertial Fusion Energy – GlobeNewswire

    Coherent Partners with LLNL’s STARFIRE Team to Drive Breakthroughs in Inertial Fusion Energy

    Gene Associated With Deadly Heart Disease in Golden Retrievers Identified – Technology Networks

    Breakthrough Discovery Uncovers Gene Behind Deadly Heart Disease in Golden Retrievers

    Monkey Island LNG Picks ConocoPhillips’ Liquefaction Technology – Hart Energy

    Monkey Island LNG Selects ConocoPhillips’ Advanced Liquefaction Technology for Next-Gen Energy Solutions

    Credo Technology Group Holding Ltd. (CRDO) Surpasses Q1 Earnings and Revenue Estimates – Yahoo Finance

    Credo Technology Group Surpasses Q1 Earnings and Revenue Expectations

    The Economist is hiring a science and technology correspondent – The Economist

    Exciting Opportunity: Become Our Next Science and Technology Correspondent!

    Blockchain lender Figure Technology seeks to raise up to $526M in IPO (FIGR:Pending) – Seeking Alpha

    Blockchain Lender Figure Technology Sets Sights on $526M in Thrilling IPO Launch

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
Earth-News
No Result
View All Result
Home Science

An effective MASH drug is good, but biotech can make it better

May 8, 2024
in Science
An effective MASH drug is good, but biotech can make it better
Share on FacebookShare on Twitter

Understanding this complex disease requires better model systems and large-scale data.

The US Food and Drug Administration recently approved Madrigal Pharmaceuticals’ Rezdiffra (resmetirom) for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) in adults. The new drug is a groundbreaking win for a disease with no previous therapy. MASH, previously known as noncirrhotic non-alcoholic steatohepatitis (NASH), occurs when excess fat cells build up in the liver, leading to inflammation, scarring and possible liver failure. It affects 1.5–6.45% of the worldwide population.

MASH has sorely tested biopharma’s tenacity and ingenuity. Over the past two decades, pharma and biotech companies globally have attempted — and failed — to develop drugs. The search for an effective drug has frustrated companies, investors and patients. Novo Nordisk, Eli Lilly, Pfizer and AstraZeneca have all tried their own MASH drugs against different pathways; some are still in phase 2 and 3 trials1, but many have been pulled in recent years when not enough positive effect was seen compared with placebo. Big pharma also has the new glucagon-like peptide-1 (GLP-1) agonists, which are being trialed to see whether they can be used against MASH. Results so far are promising, which is expected, as weight loss is the primary treatment suggested for reducing MASH progression. Considering the many failed attempts, the approval of Resmetirom is noteworthy. But as a drug, it is far from ideal: only 25–30% of patients with MASH benefit from treatment.

The main problem is that we have yet to understand the molecular mechanisms underpinning the disease. MASH is complex, and there is much to still learn about the pathways involved2. We know that it is a metabolic disorder characterized by dysregulation of glucose, lipid and bile acid metabolism. Fats accumulate in the liver and other peripheral tissues, eventually leading to liver fibrosis. However, MASH varies in its progression between individuals, and there are several layers of metabolic, genetic and epigenetic pathway changes. As a result, drugs have been developed against intermediate targets in lipid metabolism, inflammatory responses or fibrotic progression. Phase 3 clinical trial endpoints are either reduction of fatty acid accumulation or reversal in progression of fibrosis. These mitigate the end pathologies but do not necessarily to tackle disease initiation or early-stage progression.

We also lack validated biomarkers for easy or early MASH screening. Resmetirom is a thyroid hormone receptor-β (THRβ) agonist that reduces liver fibrosis, perhaps by boosting the ability of hepatocytes to burn lipids3, but we do not even know for sure how it works.

Most MASH studies are in mice, in which MASH is induced by high-fat, high carbohydrate ‘Western’ diets. Researchers cannot use cell lines or organoids because MASH development depends on the microenvironment of the liver and the metabolic response of an individual. However, the type of diet and amount of fat is critical for modeling disease progression. Diets high in different sugars, for instance, lead to varied disease phenotypes. Genetics can play a part, too, as some mouse models, such as the Foz/Foz mutant strain, develop MASH after 4–8 weeks of a Western diet rather than 16 weeks in wild type4.

Humanized mouse models, containing both human and mouse liver cells, may be better placed to tell us something about the early stages of the disease. In these chimeras, the human liver cells develop a metabolic state consistent with human fatty liver disease whereas the mouse liver cells remain normal5. The limitation here is that these mice also lack immune systems, so the inflammatory response associated with MASH in humans is missing.

While these models have been scientifically informative, they have proven impractical when screening for drug responses. Researchers usually have to repeat their experiments in multiple mouse models to show that the results are independent of any specific model6. In addition, in humans, MASH develops over years, not weeks.

In this age of big ’omics data, can we do better? First, we need a solid understanding of the biology that underlies the development of the disease. We need a global picture of the transcriptomic, proteomic and metabolic changes that occur at each stage of the disease. This disease progression in mice is often heterogeneous — but it is that way in humans too. Instead of trying to make a ‘one size fits all’ mouse model, why not capitalize on this heterogeneity and find ways to target populations at different stages, with different manifestations of MASH? Companies need practical solutions to screen for drugs that will affect the disease at each of these stages.

Some biotech companies are already thinking about this. One approach is from Gordian Biotechnology, which is looking at MASH and other complex diseases related to aging. Gordian’s mosaic screening combines gene therapy with single-cell sequencing and enables multiple drugs to be investigated in a single animal (for MASH, typically mouse or primate, but they use horse or primate models for other aging conditions). Multiple drugs can be barcoded and delivered to an organ and localized responses to each drug analyzed. Looking across a variety of animals could provide information on which drugs work best, in what phenotypes. Machine learning will also be helpful here.

Other companies are looking to move past the ‘one target, one drug’ approach and use more human-based models. Ochre Bio is developing RNA therapies targeted to the liver, using deep phenotyping of human-centric translational models. Cellarity has realized that a complex disease will likely need multiple protein targets and is using single-cell transcriptomics data combined with large perturbation datasets from human samples to find small molecules that could influence disease pathways.

The industry also needs to be more aware of patients and their disease stage during clinical trials. Often, people with MASH have comorbidities that can compromise trial results and lead to response heterogeneity. We know that obesity and type 2 diabetes are risk factors for MASH, but we do not know the exact interplay between the conditions. There need to be enough participants and the trials must be long enough to show an effect in this slow-evolving disease. Looking at endpoints, it takes over a year to see fibrosis disappear. Furthermore, liver biopsies are the only way to measure progression without clear biomarkers, and biopsies are invasive.

While it is possible that GLP-1 agonists may help MASH at early stages, there are still uncertainties around their long-term use, and MASH is a long-term disease. Biopharma has failed in its attempt to find a ‘one size fits all’ solution, but companies can do better if they stop trying to cure the symptoms and instead try to understand the underlying pathology.

>>> Read full article>>>
Copyright for syndicated content belongs to the linked Source : Nature.com – https://www.nature.com/articles/s41587-024-02265-5

Tags: BiotechEffectivescience
Previous Post

Sorry Apple faithful, there won’t be any stickers in the new iPad boxes

Next Post

Raiders Trade Rumors: LV ‘Did Not Want to Reach’ for Michael Penix Jr. in NFL Draft

Ecology issues $738K penalty against downtown Walla Walla Chevron owner – Union-Bulletin

Ecology issues $738K penalty against downtown Walla Walla Chevron owner – Union-Bulletin

September 6, 2025
What the science says about acetaminophen, pregnant mothers and autism – NBC News

What the science says about acetaminophen, pregnant mothers and autism – NBC News

September 6, 2025
RFK Jr accused of ‘reckless disregard for science and the truth’ in Senate hearing – The Guardian

RFK Jr. Faces Fierce Backlash for ‘Reckless Disregard for Science and Truth’ in Heated Senate Hearing

September 6, 2025
Start The Go-Go Years Today: Ignite Your Early Retirement Lifestyle – Forbes

Start The Go-Go Years Today: Ignite Your Early Retirement Lifestyle – Forbes

September 6, 2025
When Sports Teach More Than Skills – American Enterprise Institute

When Sports Teach More Than Skills – American Enterprise Institute

September 6, 2025
Abby Dow and England near record territory as Australia search for upset – The Guardian

Abby Dow and England Close in on Record as Australia Hunts for an Upset

September 6, 2025
America is getting the economy we voted for – Noah Smith | Substack

America Is Finally Experiencing the Economy We Created

September 6, 2025
Pendulum Announce Homecoming 2026 Australian Tour – yahoo.com

Pendulum Announces Thrilling Homecoming Tour Across Australia in 2026

September 6, 2025
HHS responds to report about autism and acetaminophen : Shots – Health News – NPR

HHS Addresses New Findings on Autism and Acetaminophen Use

September 6, 2025
September 2, 2025: Trump administration news – CNN

September 2, 2025: Trump administration news – CNN

September 6, 2025

Categories

Archives

September 2025
MTWTFSS
1234567
891011121314
15161718192021
22232425262728
2930 
« Aug    
Earth-News.info

The Earth News is an independent English-language daily published Website from all around the World News

Browse by Category

  • Business (20,132)
  • Ecology (810)
  • Economy (828)
  • Entertainment (21,705)
  • General (16,889)
  • Health (9,869)
  • Lifestyle (841)
  • News (22,149)
  • People (830)
  • Politics (835)
  • Science (16,039)
  • Sports (21,327)
  • Technology (15,808)
  • World (809)

Recent News

Ecology issues $738K penalty against downtown Walla Walla Chevron owner – Union-Bulletin

Ecology issues $738K penalty against downtown Walla Walla Chevron owner – Union-Bulletin

September 6, 2025
What the science says about acetaminophen, pregnant mothers and autism – NBC News

What the science says about acetaminophen, pregnant mothers and autism – NBC News

September 6, 2025
  • About
  • Advertise
  • Privacy & Policy
  • Contact

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

Go to mobile version